Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 17:00
2556.00
16.65 (0.66%)
VOLUME 15,558
LIVE
NSE
Apr 17, 17:00
2552.20
15.45 (0.61%)
VOLUME 289,332
Earnings News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Pharma cos may see healthy earnings growth in Q4FY14: CLSA

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

Most companies are expected to report some forex gains on hedges and foreign liabilities given the slight strengthening of rupee Q-o-Q, CLSA said....

How experts are reading Dr Reddy's Laboratories Q3 results 

3.32 pm | 11 Feb 2014 |  Source: CNBC-TV18

Q3 earnings have been broadly in line with our expectation. We were expecting good traction in bot Russia and America as they have been key drivers fo...

Dr Reddy's Labs Q3 net profit up 70% to Rs 618 cr

2.10 pm | 11 Feb 2014 |  Source: Moneycontrol.com

Net profit increased to Rs 618.53 crore from Rs 363.3 crore. Net sales grew 23.3 percent year-on-year to Rs 3,533.76 crore in the quarter ended Decemb...

Dr Reddy's Labs Q3 profit may jump 39% to Rs 506 cr: Poll 

12.20 pm | 11 Feb 2014 |  Source: CNBC-TV18

Dr Reddy's Laboratories will announce its third quarter (October-December) earnings today. According to CNBC-TV18 poll, analysts expect 39 percent gro...

Pharma companies revenues to rise 12% in Q3: Anand Rathi

5.34 pm | 03 Jan 2014 |  Source: Moneycontrol.com

Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), re...

Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr

2.23 pm | 31 Oct 2013 |  Source: Moneycontrol.com

Revenues, too, grew 16.5 percent higher-than-expected to Rs 3,357.4 crore during second quarter from Rs 2,880.9 crore in a year ago period....

Dr Reddys Labs Q2 net seen up 74% at Rs 710cr: P Lilladher

9.11 am | 31 Oct 2013 |  Source: Moneycontrol.com

According to Prabhudas Lilladher, sales of Dr Reddys Laboratories are expected to increase by 18.3 percent Q-o-Q (up 16.8 percent Y-o-Y) to Rs 3,366.1...

Dr Reddys Labs Q2 PAT seen up 39% at Rs 486cr: MOST

9.00 am | 31 Oct 2013 |  Source: Moneycontrol.com

According to Motilal Oswal, Sales of Dr Reddys Laboratories are expected to increase by 20.5 percent Q-o-Q (up 20.8 percent Y-o-Y) to Rs 3,361.5 crore...

Dr Reddy's Labs Q2 PAT may rise 22% to Rs 498 cr: Poll 

6.39 pm | 30 Oct 2013 |  Source: Moneycontrol.com

According to a CNBC-TV18 poll, profit after tax is expected to rise 22 percent year-on-year to Rs 498 crore from Rs 407.4 crore and revenues are likel...

Ranbaxy to drag; buy DRL, Glenmark; neutral on Lupin: Rathi 

3.27 pm | 30 Oct 2013 |  Source: CNBC-TV18

He is positive on Dr Reddy mainly because the company is going to benefit significantly in FY14 and FY15 from the new launches and at the same time th...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.